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Pancreatic insufficiency is a clinical manifestation characterized by the in-ability of the 15 
pancreas to release enough pancreatic enzyme into the small intestine, necessary to digest 16 
intraluminal nutrients. The lack of digestive enzymes leads to the difficulty to absorb nutrients, 17 
which drives in infants, to malnutrition and lack of growth and development, due to the loss of 18 
calories. These patients generally need oral administration of enzymes to favor lipolysis and 19 
absorption of lipids from foods. However, there are a number of food related factors (matrix, 20 
type of fat, etc.) and digestive environment (intestinal pH, bile concentration, among others), 21 
which will influence the digestibility of nutrients.  22 
In this study, an “in vitro” digestion model was used to characterize the kinetics of the lipolysis 23 
of milk-fat catalyzed by an enzymatic supplement. Different intestinal conditions (pH (6, 7 and 24 
8) and bile concentrations (1, 5 and 10 mml·L-1)) were simulated, using a fixed concentration 25 
of supplement. Gastro-Intestinal conditions, significantly affected lipolysis. High pH and bile 26 
concentrations were translated into low values of the Michaelis-Menten constant and high 27 
values of the catalytic constant. The kinetic parameters obtained from this work allowed 28 
estimating the dose of enzymatic supplement required to optimize the lipolysis of milk-fat 29 
under different intestinal environments, sufficient and insufficient pancreatic conditions.  30 
 31 
Keywords: milk “in vitro” digestion; milk-fat lipolysis; kinetics; pancreatic insufficiency; 32 
supplementation therapy  33 
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1. Introduction 34 
Exocrine Pancreatic insufficiency (EPI) is an associated disorder, which occurs in several 35 
diseases including pancreatic cancer, chronic pancreatitis (CP), cystic fibrosis (CF) and 36 
because of pancreatic surgery. EPI may occur due to loss of functional parenchyma (atrophy), 37 
blockage of the pancreatic duct, or postprandial asynchrony (Sikkens et al., 2010). In EPI, the 38 
obstruction of the pancreatic duct produces an insufficient secretion of sodium bicarbonate and 39 
pancreatic juice, containing digestive enzymes. Besides this lack of digestive enzymes, the 40 
decrease of pancreatic juice may also cause variations within the intestinal pH, this leading to 41 
nutrients mal-digestion and mal-absorption (Layer & Keller, 2003; Naikwade et al., 2009; 42 
Whitcomb et al., 2010). In this scenario, the hydrolysis and absorption of lipids are the most 43 
jeopardized, due to pancreatic lipase is the main responsible of lipolysis (Sikkens et al., 2010).  44 
Pancreatic Enzyme Replacement Therapy (PERT) consists on the oral administration of an 45 
enzymatic supplement of exocrine pancreatin to promote nutrients digestion and absorption 46 
(Armand et al., 2011). Even tough PERT has led to a large improvement of fats digestion and 47 
absorption, satisfactory levels of fat absorption are not often achieved. While the current 48 
guidelines for CF recommend an enzyme dose of 2000-4000 Lipase Units (LU)/ g fat (Turck 49 
et al., 2016), the optimal doses are still uncertain since they depend on food factors as well as 50 
on gastrointestinal (GI) conditions. Nowadays, the only available parameters to guide health 51 
professionals on adjusting the prescribed doses are based on the overall fat content of the meals 52 
or on patients body weight (Turck et al., 2016).  53 
Individual factors such as gastric empting time, intestinal pH, intestinal transit, etc., may affect 54 
fat digestibility (Borowitz et al., 2013; Rovner et al., 2013). The decrease of pancreatic and/or 55 
bile secretion into the small intestine is frequently observed in some GI diseases (Layer & 56 
Keller, 2003; Whitcomb et al., 2010). As a consequence, the duodenal pH becomes more acidic 57 
(around pH 6) than in healthy person (around pH 7), while bile concentration might decrease 58 
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even 10 fold (1 mM) compared to a healthy adult (10 mM) (Aseeri et al., 2012; Borowitz et al., 59 
2013).  60 
On the other hand, factors related to foods such as fat content, type of fat, or food matrix can 61 
influence the enzyme activity. Therefore, the rate and extent of lipolysis will depend on the 62 
kinetic parameters of the enzyme for each substrate and medium characteristics. The pH-stat 63 
titration method is, in association with static systems, a classical approach that allows for 64 
monitoring the intestinal stage of “in vitro” digestions by directly providing the dynamics of 65 
the reaction (Li et al., 2011; Mat et al., 2016).  66 
Lipolysis is an interfacial reaction and where the rate of the reaction depends on the emulsion 67 
characteristics (i.e. droplet size, concentration of fat…). In the majority of studies published 68 
until this date, the amount of free fatty acids (FFAs) released under simulated intestinal 69 
conditions has been monitored using formulated emulsions. That means that the characteristics 70 
of these emulsions were known and pre-designed (i.e. fat concentration, droplet size, 71 
concentration of surfactant…) (Charoen et al., 2012; Lesmes & McClements, 2012; Mat et al., 72 
2016; Waraho et al., 2011). This approach makes sense since, in fact, lipids are most often 73 
consumed in the form of oil in water emulsions (milk, sauces…) characterized by their 74 
formulation and process conditions. However, one has to take into account that transformations 75 
during digestion may lead to changes in the oil/water interface area (Giang et al., 2015; Mat et 76 
al., 2016). Those changes will lead to unknown and maybe less favorable characteristics of the 77 
emulsions that will have different consequences on lipolysis, thus the importance of monitoring 78 
the reaction using food systems instead of predesigned model systems. 79 
The novel approach proposed in this work is based on enzyme kinetics methodology. As stated 80 
above, health and nutritional status of patients with pancreatic insufficiency strongly depends 81 
on the precise doses of enzyme supplements. In this sense, a complex food such as milk, a 82 
processed o/w emulsion where the fat globules are dispersed within the aqueous phase, has 83 
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been used to estimate the saturation substrate concentration for a certain amount of enzyme 84 
under “in vitro” simulated conditions.  85 
The aim of the present work was to explore the above-explained approach to analyze the 86 
influence of some GI factors (pH and bile concentration) on the pancreatic lipase’s affinity for 87 
milk-fat. The parameters obtained from this approach will describe the enzymatic supplement 88 
performance on milk-fat lipolysis and will contribute to better adjust the required dose for an 89 
optimal digestion. 90 
 91 
2. Materials and methods 92 
2.1. Materials 93 
Pancreatic enzyme supplement (Kreon® 10,000 LU), was kindly donated by “Hospital 94 
Universitari Politècnic La Fe” (Valencia, Spain). Each capsule contains 150 mg of porcine 95 
pancreatic enzyme as gastro-resistant microspheres equivalent to 10,000 lipase units, 8,000 96 
amylase units, and 600 protease units. The other chemicals used for the “in vitro” digestion: 97 
pepsin from porcine gastric mucosa, bovine bile extract, KCl, KH2PO4, NaHCO3, NaCl, MgCl2 98 
(H2O)6, (NH4)2CO3 y CaCl2 and Triton X-100 were obtained from Sigma-Aldrich Chemical 99 
Company (St Louis, MO, USA). NaOH (1, 0.1 and 0.05 N) and HCl 1 N, were acquired from 100 
AppliChem Panreac. Full fat milk (3.6 % f.m.) was purchased at a local supermarket.  101 
 102 
2.2. Experimental Design 103 
The digestion of emulsified lipids depends on different parameters such as their compositional 104 
and structural properties (Armand, 2007; Li et al., 2011; Li & McClements, 2010; Zhu et al., 105 
2013), the composition and the surface area of the interface surrounding, or the droplet size 106 
(Borel et al., 1994; Li et al., 2011; Li & McClements, 2010), as well as the enzyme’s affinity 107 
for the interfacial layer (Giang et al., 2015; Hur et al., 2009). The velocity of the reaction might 108 
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be correlated with the concentrations of substrate [S] and enzyme [E] as follows (equation 1):  109 
𝑟 = #$%&∙ ( )⋅ +
#,-	 + 	
                                                   (equation 1) 110 
where, r is the reaction velocity (µmol/ mL · min); kcat is the catalytic constant (s-1); km is the 111 
Michaelis-Menten constant (mM), [S] is the substrate concentration (mM), and [E]0, is the 112 
initial enzyme concentration (mM). 113 
The kinetic parameters of the lipolysis reaction of milk-fat during the duodenal digestion 114 
processes were estimated. At this purpose, milk samples representing ten different amounts of 115 
fat substrate (table I) were digested for each one of the experimental conditions, intestinal pH-116 
bile concentration. Full fat milk (3.6 % f.m.) was used for the experiments (1L package for 117 
each experiment), so the amount of fat for each experiment was calculated according to the 118 
initial amount of fat in the mil package. Furthermore, this experimental design allowed for 119 
assessing the influence of intestinal conditions (pH and bile concentration) on the lipolysis 120 
reaction. Every experimental condition was assayed at least in triplicate.  121 
 122 
Table I: Volume of milk samples (mL); Mass of milk samples (g); fat concentration on the final digestion 123 
mixture (g/L) and substrate concentration (mmol of milk-fat/L) used for each one of the pH-bile combinations. 124 







1 1.33  1.37 1.40 1.66 
2 2.70  2.78 2.66 3.24 
3 4.07  4.19 3.87 4.71 
4 5.38  5.54 5.00 6.02 
5 6.76  6.96 6.01 7.32 
6 8.07  8.31 6.95 8.46 
7 10.78  11.11 8.80 10.64 
8 13.50  13.91 10.32 12.58 
9 16.18  16.67 11.73 14.28 
10 18.86  19.43 13.00 15.82 





2.3. “in vitro” digestion process 128 
The methodology used for the present study was based on the harmonized static “in vitro” 129 
protocol published by Minekus et al. (2014) with some modifications. Summarizing, for the 130 
oral stage, the milk sample was mixed with Simulated Salival Fluid (SSF) in a ratio 1:1 (v/v) 131 
at 37º C. After that, for the gastric stage, oral bolus was mixed with the Simulated Gastric Fluid 132 
(SGF) in an oral bolus: SGF ratio of 1:1 (v/v), the pH was adjusted to 3 with HCl, and the mix 133 
was shaken at 37º C for 2h in an incubator chamber Selecta (JP Selecta SA, Barcelona), using 134 
an Intell-Mixer RM-2 (Elmi Ltd, Riga, LV-1006, Latvia), to agitate the samples head- over-135 
heels at 55 rpm. Finally, for the intestinal stage, the gastric chime was mixed with the Simulated 136 
Intestinal Fluid (SIF) to obtain a final ratio of gastric chime to SIF of 1:1 (v/v). The pH was 137 
then adjusted to 7 with NaOH and the mix continued to be shaken at 37º C for 2h. However, in 138 
the present study, in order to analyze the influence of the intestinal pH and bile concentration 139 
on milk-fat lipolysis, some modifications were made. Porcine pancreatin was replaced by the 140 
enzymatic supplement Kreon® (0.21 g/L, 8.27 LU/ mL in the final digestion mixture). The 141 
experimental design consisted of two different variables (pH and bile concentration) at 142 
different levels. Three different levels were used for intestinal pHs (6, 7, 8); these values were 143 
chosen as they belong within the optimum working pH for the enzyme (Kreon®), as well as 144 
for being close to the physiological duodenum conditions (Etienne-mesmin & Denis, 2012). 145 
Moreover, two levels were used for the duodenal bile concentrations (1, and 10 mM). From the 146 
different possibilities, the combination pH 7/ bile 10 mM, was considered as the standard, while 147 
pH 6/ bile 1 mM, could correspond to an extreme case in EPI disorder (Aseeri et al., 2012; 148 
Minekus et al., 2014). In addition, a central point consisting on an extra combination (pH 7 and 149 
bile concentration 5 mM) was added to the experimental design in order to strengthen it and 150 
make it more robust. The amounts and composition of the simulated digestive fluids are 151 
summarized in table II. They were made up from stock solutions: salival (SSS), gastric (SGS) 152 
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and intestinal (SIS), according to Minekus et al. (2014). Pepsin was added into the SGF to 153 
reach a concentration in the gastric mixture of (2000 U/mL). Bile was added to the SIF in order 154 
to reach a final concentration in the intestinal mix of 1, 5 or 10 mM depending on the 155 
experimental design. 156 
 157 
Table II: Composition of simulated digestion fluids. 158 
Constituent SSF SGF SIF 
 mmol · L-1 mmol · L-1    mmol · L-1 
KCl  15.1 6.9 6.8 
KH2PO4 3.7 0.9 0.8 
NaHCO3 13.6 25 85 
NaCl  - 47.2 38.4 
MgCl2(H2O)6  0.15 0.1 0.33 
(NH4)2CO3 0.06 0.5 - 
CaCl2 1.5  0.15  0.6  
SSF (Simulated Salival Fluid), SGF (Simulated Gastric Fluid), SIF (Simulated Intestinal Fluid). The addition 159 
of pepsin, Ca2+ solution and water will result in the correct electrolyte concentration in the final digestion 160 
mixture. 161 
 162 
2.4. Lipolysis kinetics assessment 163 
The progress of lipolysis during the intestinal stage was monitored by two different methods:  164 
a) pH-STAT method  (the intestinal stage took place in a 902 STAT titrino (Metrohm)); this 165 
method, commonly used to characterize the “in vitro” digestibility of lipids under simulated 166 
small intestine conditions, measures the amount of free fatty acids (FFAs) released from lipids, 167 
usually triacylglcyerols (TAGs), after lipase addition at pH values close to neutral (Li & 168 
McClements, 2010). In our case, the total of gastric chime in a 50 mL falcon tube was poured 169 
into the reaction vessel and the SIF and Kreon® were added. This reaction was then monitored 170 
during 30 minutes, which allowed getting the linear slope at the beginning of the lipolysis 171 
reaction. Of notice, NaHCO3 was replaced by NaCl in all the simulated fluids (SSF, SGF and 172 
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SIF) at the same molar ratio, in order to maintain the same ionic strength and avoid its buffering 173 
effect (Mat et al., 2016). 174 
b) Rapid enzymatic kit (spectrophotometric method). The intestinal stage took place in the same 175 
tubes and incubator chamber as the gastric stage; this methodology was applied to the standard 176 
experimental conditions pH 7/ 10 mM, in order to test whether the pH changes registered by 177 
the pH-stat were the result of the FFA produced by lipid digestion. For this purpose, a substrate 178 
concentration of 6.9 mg fat / mL (8.09 mL of milk) was used. Immediately after the gastric 179 
stage, the SIF and Kreon® were added to a 50 mL falcon tube containing the gastric chime, pH 180 
was adjusted to 7, and samples were rotated head- over-heels at 55 rpm for 30 min at 37 ºC, 181 
with the same agitator and chamber used for the gastric stage. To analyze the FFAs release, 182 
aliquots of the digestion fluids (100 uL) were removed at different interval times during the 183 
intestinal stage (0, 5, 10, 25 and 30) and mixed with 10 mL of a solution made of 5.6 % Triton 184 
X-100 and 6 % ethanol in water (to solubilize the free fatty acids and ensure to stop lipase 185 
activity). The free fatty acids release was measured using a free fatty acid spectrophotometric 186 
assay kit (Roche Diagnostics, Indianapolis, IN, USA) in a spectrophotometer (UV/vis, 187 
Beckman Coulter) (Lamothe et al., 2014). Palmitic acid standard was used for quantitative 188 
determination of FFA. Digested fat was estimated assuming the maximum release of 2 moles 189 
of fatty acids per 1 mole of triglycerides (Hunter, 2001). 190 
 191 
2.5. Optical microscopy  192 
Aliquots (100 µL) from the samples digested in the incubator chamber were taken at the same 193 
time intervals (0, 5, 10, 25 and 30), mixed with a solution of Red Oil (5 % in isopropanol) in a 194 
4:1 volume ratio, vortexed for 10 s and incubated for 10 min at 37º C to stain the fat. A drop 195 
of this mixture was then placed on a microscope slide, covered by a cover slip, on an optical 196 
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microscope (Leica DM 5000 B). The images were acquired using a camera (Leica DFC, 550) 197 
connected to a digital image processing system.  198 
 199 
2.6. Statistical analyses 200 
Statistical analysis of variance (simple ANOVA) was performed using Statgraphics Centurion. 201 
All the experiments were performed at least in duplicate and the results presented are always 202 
the mean values ± standard deviation.  203 
Principal Component Analysis, PCA, (SPSS) was also applied to assess whether the velocities 204 
of lipolysis reaction could be grouped depending on the gastrointestinal conditions or the 205 
substrate concentration. 206 
 207 
3. Results and discussion 208 
The pH-stat method, has been commonly used to characterize the amount of free fatty acids 209 
(FFAs) released under simulated intestinal conditions. Generally, this methodology has been 210 
proved to successfully work with o/w emulsions, when fat digestion is catalyzed by lipases 211 
(Charoen et al., 2012; McClements et al., 2008; Waraho et al., 2011). However, in the present 212 
work, a more complex system, milk, was digested using an enzymatic supplement (Kreon®). 213 
The enzymatic activity of this enzyme (amylase, protease and lipase activities) might have 214 
produced digestion products other than FFA such as peptides and amino acids that would have 215 
an alkalinisation effect on the digestion mixture. The pH changes registered by the pH-stat 216 
might therefore, not only occur as a result of the FFA produced by lipid digestion. In order to 217 
assess whether the data obtained by the pH-stat method were those corresponding to the FFA 218 
release during the intestinal stage, an extra experiment was performed. This was undertaken at 219 
pH 7/ bile 10 mM with a substrate concentration of 6.9 mg fat /mL using both, an enzymatic 220 
kit (Lamothe et al., 2012, 2014), and the pH-stat method (Li et al., 2011; Li & McClements, 221 
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2010; Mat et al., 2016). Figure 1 illustrates the linear correlation between the two sets of data, 222 
confirming that the pH variations registered by the pH-stat method can be used to estimate the 223 
FFAs released during milk-fat lipolysis, and therefore, to analyze the influence of intestinal pH 224 
and bile concentration on lipolysis kinetics. 225 
 226 
Figure 1: linear correlation between the two sets of data for the lipolysis (%), obtained by the enzymatic kit vs 227 
the pH-stat data for the simulated intestinal conditions pH 7 / bile 10 mM. The dots correlate the amount of 228 
digitised TAG (%) measured at different interval points (0, 5, 10, 25 and 30 min) of intestinal stage. 229 
 230 
A total of ten curves of lipolysis progress for the different amounts of substrate (1.4 to 13 mg 231 
fat / mL) were experimentally obtained for each of the combinations pH-bile concentration. As 232 
example, Figure 2 shows the curves of lipolysis progress for a selection of substrate amounts 233 
(1.4, 5.0, 8.8 and 13.0 mg fat / mL), in this case at 10 mM bile concentration for pH 6-7-8. The 234 
progress curves of lipolysis illustrate that the rate of the enzymatic reaction and the extent of 235 
fat digestion, are strongly dependent on both the pH of the medium and the biliary 236 
concentration used, as one would have expected. The results show that the enzymatic activity 237 
of the enzymatic supplement was much more effective at pH 7 and 8, and 10 mM concentration, 238 
both from the kinetic point of view (velocity of the reaction) and from the point of view of the 239 
lipolysis extent (% of Free Fatty Acids (FFA) released). The influence of these variables is also 240 
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evident in the pattern or shape of the curves, in which, depending on the conditions, the 241 
interfacial activation period can be observed with greater or less clarity. The activation period 242 
corresponds to the initial stretch in which the enzyme adsorbs to the surface of the fat droplets. 243 
When the enzyme comes into contact with the interface, the dielectric environment on the 244 
protein surface is modified so that electrostatic interactions are enhanced. This allows the 245 
displacement of the active site cover (Anthonsenl et al., 1995; Foresti & Ferreira, 2004) and 246 
the restructuring of the conformation of the molecule (Aloulou et al., 2006; Jensen et al., 2002; 247 
Lin et al., 2007). As a result, the amino groups are exposed in a suitable orientation, allowing 248 
access to the active center, until that moment inaccessible (González-Bacerio et al., 2010). Its 249 
duration (activation time) depends on the enzyme concentration and the release of fatty acids. 250 
During this activation process, a competition is established for the oil / water interface between 251 
the lipases and other emulsifying compounds present in the system surrounding the fat droplets. 252 
In the case of the system used in this work (milk), there could be a competition between the 253 
enzyme and the caseins to be positioned at the oil / water interface. At very low enzyme 254 
concentrations, there may not be sufficient enzyme to displace the caseins and therefore an 255 
inadequate contact between the enzyme and the substrate would be established (Macierzanka 256 
et al., 2009). At higher concentrations of fat, depending on the pH conditions of the medium 257 
and biliary concentration, the interfacial stage could be clearly observed, with an initial rate of 258 
very low FFA release, which can be explained based on the activation time required so that the 259 
enzyme moves the caseins and reaches the interface of the substrate. However, under certain 260 
conditions (pH 7-8, 10 mM), these displacement and adsorption processes occurred very 261 
rapidly and lipid digestion begun almost immediately. As the fat concentration increased and 262 
therefore the enzyme: substrate (UL / g fat) ratio decreased, the interfacial activation time was 263 
increasingly longer. In contrast, for the lower substrate concentrations (0.05 g and 0.25 g), this 264 





Figure 2: Curves of lipolysis progress during the intestinal stage obtained by the pH-stat (NaOH 0.05 N) with 268 
enzymatic supplement Kreon® (0.21 g/L, 8.27 LU/ mL in the final digestion mixture), for the experimental 269 
conditions pH 7 /10 mM.  270 
 271 
Once the activation time finished, the constant reaction rate period begun, step in which the 272 
rate was dependent on the pH and the biliary concentration in the reaction media. This can be 273 
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observed in Figure 3, where for each of the pH and biliary concentration conditions tested, the 274 
velocity in the linear section of the progress curve was calculated (Vmax). This allowed the 275 
correlation curves to be plotted between the reaction velocity (Vmax) in the linear section (µmol 276 
/ min · mL), and substrate concentration [S], for the enzyme concentrations assayed. As 277 
expected, the rate of lipid digestion increased with pH and biliary concentration, the latter 278 
related to the emulsifying power of bile salts, increasing the contact surface between the 279 
enzyme and fat droplets, so that the reaction happens at a faster rate (Maldonado-Valderrama 280 







Figure 3: Velocity of the reaction (r) (µmol/min·mL) vs substrate concentration [S] (mM) for the different 286 
combinations pH (6, 7 and 8) and bile concentrations (1, 5 and 10 mM). Michaelis Menten fitting models. The 287 
dots are the average of at least two replicates. 288 
 289 
A PCA was conducted in order to better understand the influence of the gastrointestinal 290 
conditions on the velocity of the lipolysis reaction. Figure 4 illustrates the two-dimensional 291 
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plots of the sample scores (slopes of the curves for each experimental condition (Vmax)) and 292 
compound loadings (pH, Bile concentration and substrate concentration) obtained by the PCA. 293 
The first three dimensions explained 96.4 % of the total variance (PC1, 43.3 %; PC2, 25.6% 294 
and PC3, 25.5 %).  295 
 296 
 297 
Figure 4: Biplots for the different velocities of reaction (r) (light markers correspond with the lower fat 298 
concentration (1.4 mg/mL) and dark markers with the highest fat concentration (13 mg / mL)), depending on the 299 
different parameters (Substrate concentration, pH and bile concentration) obtained by the PCA. (a) PC1 vs PC2 300 
and (b) PC1 vs PC3 (PC1: 43.6 %, PC2: 25.6 % and PC3: 25.5 %).  301 
 302 
As it can be observed in Figure 4a, the velocities (Vmax) of the different assays are grouped 303 
together in the plot according to the different intestinal conditions (pH and bile concentration). 304 
PC1 clearly differentiates between pHs, with the velocities (Vmax) obtained under pH 6 at the 305 
left side of the plot and the ones obtained under pH 8 at the right side of the plot. On the other 306 
hand, PC2 differentiates between bile concentrations, with velocities (Vmax) obtained with the 307 
lower concentration (1 mM) at the bottom of the plot and the ones obtained with the highest 308 
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concentration (10 mm) at the top of the plot. Furthermore, PC1 represented vs PC3 (Figure 309 
4b) illustrates the influence of the amount of substrate on the velocity of the reaction. In this 310 
case, velocities (Vmax) obtained with the higher fat concentration can be found at the top of the 311 
plot. Summarizing, the three parameters influenced the velocity of the reaction with the major 312 
reaction rates reached at high intestinal pH (7 or 8). In addition, the effect of pH on this velocity 313 
became more important at high bile concentrations (5 and 10 mM) and high substrate 314 
concentrations. 315 
The experimental results (the calculated slopes of the linear section of each curve, (Vmax)) were 316 
fitted into Michaelis-Menten equations, in order to obtain the corresponding values of the 317 
Michaelis-Menten constant (km) and the catalytic constant (kcat) (Table III). The statistical 318 
analysis indicated that both pH and bile concentration, as well as their interaction significantly 319 
affected both kinetic parameters (p < 0.05).  It should be noted that the studied system was a 320 
heterogeneous reaction in which the enzyme, being soluble, only had access to the molecules 321 
of substrate on the surface of the drop of the dispersed phase (fat globules) (García, 2005). The 322 
enzyme activity would then not depend on the molar concentration of the enzyme, but on the 323 
concentration of substrates at the interfaces (Reis et al., 2009). Therefore, the specific 324 
interfacial area of the emulsion would be a critical parameter in this type of systems, just as the 325 
substrate concentration is in homogeneous systems. However, milk being a homogeneous 326 
processed food, was considered for the calculations, to be a homogeneous system (where the 327 
substrate is dispersed throughout the reaction volume) and not a heterogeneous system. The 328 
increase of pH and bile concentration led to a higher affinity of the enzyme for the substrate 329 
(decreasing values of the Michaelis-Menten constant (km)). In a similar way, the catalytic 330 
constant, (kcat), related with the velocity of the reaction, was dependent on the pH and bile 331 
concentration (in this case kcat increased as the pH and bile concentration did). Accordingly, 332 
the extent of lipolysis will depend on both parameters. Bile salts are essential as they compete 333 
18 
 
to remove other compounds such as proteins and emulsifiers from the fat droplets surface and 334 
allow lipase and co-lipase to absorb onto the lipid surface and instigate lipolysis. 335 
Complementary, bile salts motivate lipolysis-products transportation (mainly free fatty acid 336 
and monoglycerides) from the lipid surface to the intestinal fluid and their further micellation 337 
(Maldonado-Valderrama et al., 2011). In this case, the effectiveness of the enzymatic 338 
supplement seemed to be highly dependent on the removal of caseins, precipitated after gastric 339 
digestion, from the fat droplets surface by bile salts. As expected, pH of the intestinal stages 340 
resulted crucial as well, because of the absence of pancreatic activity under 5.7 ranging the 341 
optimum pH for pancreatic enzymes from 7 to 8 (González-Bacerio et al., 2010; Prazeres et 342 
al., 1994). This allowed lipase and its cofactor co-lipase to adsorb onto the lipid surface and 343 
instigate lipolysis.   344 
Table III: Michaelis-Menten constant (km) and catalytic constant (kcat) for the different 345 
combinations: pH and bile concentration 346 
pH / bile 





6/1 10.58 ± 0.07 (e) 0.391 ± 0.002 (a) 
6/10 5.06 ± 0.14 (d) 1.030 ± 0.073 (c) 
7/1 3.56 ± 0.18 (c) 0.819 ± 0.022 (b) 
7/5 2.56 ± 0.05 (b) 3.223 ± 0.082 (e) 
7/10 1.47 ± 0.23 (a) 3.515 ± 0.045 (f) 
8/1 2.64 ± 0.08 (b) 2.785 ± 0.007 (d) 
8/10 1.56 ± 0.13 (a) 3.612 ± 0.009 (f) 
All values are expressed as mean ± SD of at least two replicates. 347 
Different superscripts within a same column means statistical 348 
differences by Tukey Kramer test (p<0.05).Total 349 
 350 
Furthermore, a comparative analysis of the state of the digested milk sample was performed by 351 
microscopy. Figure 5 illustrates the lipolysis extent after 5 and 30 minutes of intestinal stage, 352 
for the experimental conditions pH 6/1 mM (A and C) y pH 7/10 mM (B and D). Even after 30 353 
minutes of intestinal digestion, a great amount of fat globules was still observed under pH 6/1 354 
mM (7.5 % of lipolysis extent). However, for pH 7/10 mM, almost the totality of the fat 355 
appeared to be digested after 30 minutes of intestinal digestion (80.3 %). These results agree 356 
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with those obtained previously, since, for pH 6/1 mM and pH 6/10 mM, the smallest kinetic 357 
parameters were obtained. These kinetic parameters allowed for estimating the reaction 358 
velocity of fat hydrolysis under different intestinal conditions. In this sense, table IV gathers 359 
the calculated enzyme concentration ratios (R) needed under the different intestinal conditions 360 
to obtain the same reaction velocity than in the standard conditions (pH 7 and 10 mM bile 361 
concentration).  As expected, the highest value of the ratio (R) corresponds to the conditions 362 
of pH 6/1 mM indicating that under these conditions the enzyme is in a very unfavorable 363 
environment. On the contrary, at pH 8 and bile concentration of 10 mM, the amount of enzyme 364 
needed was the same than for the standard conditions (pH 7 and 10 mM bile). All this confirmed 365 
the great influence of these physiological parameters (intestinal pH and bile concentration) on 366 
the lipolysis of fat. 367 
 368 
Figure 5: Optical microscopy images (20x) from the milkfat digested aliquots after 5 and 30 minutes of the 369 
intestinal stage for two experimental conditions: pH 6/1 mM (A and C (1.1 ± 0.2 % and 7.5 ± 0.8 % of lipolysis 370 
extent respectively)) and C) y pH 7/10 mM (B and D (30.4 ± 0.5 % and 80.3 ± 1.5 % of lipolysis extent 371 






Table IV: R ratio between de enzyme concentrations needed at different pH/bile concentration to obtain the 376 





4. Conclusions 382 
The pH stat method was successfully used to monitor the free fatty acids release during the “in 383 
vitro” digestion process of a food sample (milk). The Michaelis-Menten constant (km) 384 
decreased and the velocity of the lipolysis reaction (r) increased as pH and bile concentrations 385 
did (pH 7/10 mM y pH 8/10 mM). The knowledge of kinetics behavior of fat-milk hydrolysis 386 
allowed estimating the amount of substrate to optimize the enzymatic supplement (Kreon®) 387 
activity required under different intestinal conditions of pH and bile concentration.  388 
The results obtained in the present study point out the huge influence that the alteration of these 389 
physiological parameters (intestinal pH and bile concentration) might have on fat lipolysis. 390 
These GI alterations together with some inherent to food factors such as matrix characteristics, 391 
processing, interactions, etc. need to be better explored to assist food industry to develop tailor-392 
made foodstuffs and to help health professional and dieticians to adapt the existing nutritional 393 
guidelines.  394 
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6/1 42.04 ± 0.36 (d) 
6/10 8.37 ±  0.41 (c) 
7/1 7.92 ± 0.09 (c) 
7/5 1.57 ± 0.06 (b) 
8/1 1.85 ± 0.04 (b) 




Aloulou, A., Rodriguez, J. A., Fernandez, S., van Oosterhout, D., Puccinelli, D., & Carriére, F. 401 
(2006). Exploring the specific features of interfacial enzymology based on lipase studies. 402 
Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, 1761(9), 995–403 
1013. http://doi.org/10.1016/j.bbalip.2006.06.009 404 
Anthonsenl, H. W., Baptistal, A., Drablprsl, F., Martel, P., Petersen, S. B., Sebastiiio, M., & 405 
Vaz, L. (1995). evolution. Biotechnology Annual Review, 1, 315–371. 406 
Armand, M. (2007). Lipases and lipolysis in the human digestive tract: where do we stand? 407 
Current Opinion in Clinical Nutrition and Metabolic Care, 10(2), 156–164. 408 
http://doi.org/10.1097/MCO.0b013e3280177687 409 
Armand, M., Borel, P., Ythier, P., Dutot, G., Melin, C., Senft, M., … Lairon, D. (1992). Effects 410 
of droplet size, triacylglycerol composition, and calcium on the hydrolysis of complex 411 
emulsions by pancreatic lipase: an “in vitro” study. The Journal of Nutritional 412 
Biochemistry, 3(7), 333–341. http://doi.org/10.1016/0955-2863(92)90024-D 413 
Armand, Fieker, A. P., & Philpott, J. (2011). Enzyme replacement therapy for pancreatic 414 
insufficiency: present and future. Clinical and Experimental Gastroenterology, 4(1), 55. 415 
http://doi.org/10.2147/CEG.S17634 416 
Aseeri, A., Brodlie, M., Lordan, J., Corris, P., Pearson, J., Ward, C., & Manning, N. (2012). 417 
Bile acids are present in the lower airways of people with cystic fibrosis. American 418 
Journal of Respiratory and Critical Care Medicine, 185(4), 463–463. 419 
Borel, P., Armand, M., Ythier, P., Dutot, G., Melin, C., Senft, M., … Lairon, D. (1994). 420 
Hydrolysis of emulsions with different triglycerides and droplet sizes by gastric lipase “in 421 
vitro”. Effect on pancreatic lipase activity. The Journal of Nutritional Biochemistry, 5(3), 422 
124–133. http://doi.org/10.1016/0955-2863(94)90083-3 423 
Borowitz, D., Gelfond, D., Maguiness, K., Heubi, J. E., & Ramsey, B. (2013). Maximal daily 424 
22 
 
dose of pancreatic enzyme replacement therapy in infants with cystic fibrosis: A 425 
reconsideration. Journal of Cystic Fibrosis, 12(6), 784–785. 426 
http://doi.org/10.1016/j.jcf.2013.05.011 427 
Charoen, R., Jangchud, A., Jangchud, K., Harnsilawat, T., Decker, E. A., & McClements, D. 428 
J. (2012). Influence of interfacial composition on oxidative stability of oil-in-water 429 
emulsions stabilized by biopolymer emulsifiers. Food Chemistry, 131(4), 1340–1346. 430 
http://doi.org/10.1016/j.foodchem.2011.09.128 431 
Etienne-mesmin, L., & Denis, S. (2012). Relevance and challenges in modeling human gastric 432 
and small intestinal digestion(review,2012).pdf. Trends in Biotechnology, 30(11). 433 
Foresti, M. L., & Ferreira, M. L. (2004). Computational Approach to Solvent-Free Synthesis 434 
of Ethyl Oleate Using Candida r ugosa and Candida a ntarctica B Lipases. I. Interfacial 435 
Activation and Substrate (Ethanol, Oleic Acid) Adsorption. Biomacromolecules, 5(6), 436 
2366–2375. http://doi.org/10.1021/bm049688o 437 
García, M. (2005). Hidrolisis enzimática de triglicéridos en emulsiones O/W. Aplicación a 438 
formulaciones detergentes. Hidrolisis Enzimática de Trigliceridos en Emulsiones O/W. 439 
Aplicación a Formulaciones Detergentes. Universidad de Granada. 440 
Giang, T. M., Le Feunteun, S., Gaucel, S., Brestaz, P., Anton, M., Meynier, A., & Trelea, I. C. 441 
(2015). Dynamic modeling highlights the major impact of droplet coalescence on the 442 
invitro digestion kinetics of a whey protein stabilized submicron emulsion. Food 443 
Hydrocolloids, 43, 66–72. http://doi.org/10.1016/j.foodhyd.2014.04.037 444 
González-Bacerio, J., Rodríguez Hernández, J., & del Monte Martínez, A. (2010). Lipases: 445 
enzymes with potential for the development of immobilized biocatalysts by interfacial 446 
adsorption. Revista Colombiana de Biotecnología, 12(1), 113–140. 447 
Hunter, E. J. (2001). Studies on effects of dietary fatty acids as related to their position on 448 
triglycerides. Lipids, 36(7), 655–668. http://doi.org/10.1007/s11745-001-0770-0 449 
23 
 
Hur, S. J., Decker, E. A., & McClements, D. J. (2009). Influence of initial emulsifier type on 450 
microstructural changes occurring in emulsified lipids during “in vitro” digestion. Food 451 
Chemistry, 114(1), 253–262. http://doi.org/10.1016/j.foodchem.2008.09.069 452 
Jensen, M. Ø., Jensen, T. R., Kjaer, K., Bjørnholm, T., Mouritsen, O. G., Peters, G. H., … 453 
Peters, G. H. (2002). Orientation and conformation of a lipase at an interface studied by 454 
molecular dynamics simulations. Biophysical Journal, 83(1), 98–111. 455 
http://doi.org/10.1016/S0006-3495(02)75152-7 456 
Lamothe, S., Azimy, N., Bazinet, L., Couillard, C., & Britten, M. (2014). Interaction of green 457 
tea polyphenols with dairy matrices in a simulated gastrointestinal environment. Food & 458 
Function, 5(10), 2621–31. http://doi.org/10.1039/c4fo00203b 459 
Lamothe, S., Corbeil, M.-M., Turgeon, S. L., & Britten, M. (2012). Influence of cheese matrix 460 
on lipid digestion in a simulated gastro-intestinal environment. Food & Function, 3(7), 461 
724–31. http://doi.org/10.1039/c2fo10256k 462 
Layer, P., & Keller, J. (2003). Lipase Supplementation Therapy: Standards, Alternatives, and 463 
Perspectives. Pancreas, 26(1), 1–7. http://doi.org/10.1097/00006676-200301000-00001 464 
Lesmes, U., & McClements, D. J. (2012). Controlling lipid digestibility: Response of lipid 465 
droplets coated by ??-lactoglobulin-dextran Maillard conjugates to simulated 466 
gastrointestinal conditions. Food Hydrocolloids, 26(1), 221–230. 467 
http://doi.org/10.1016/j.foodhyd.2011.05.011 468 
Li, Y., Hu, M., & McClements, D. J. (2011). Factors affecting lipase digestibility of emulsified 469 
lipids using an “in vitro” digestion model: Proposal for a standardised pH-stat method. 470 
Food Chemistry, 126(2), 498–505. http://doi.org/10.1016/j.foodchem.2010.11.027 471 
Li, Y., & McClements, D. J. (2010). New Mathematical Model for Interpreting pH-Stat 472 
Digestion Profiles: Impact of Lipid Droplet Characteristics on “in vitro” Digestibility. 473 




Lin, M.-C., Lu, C., Cheng, Y., Lin, Y.-F., Lin, C.-S., & Lin, G. (2007). Inhibition or activation 476 
of Pseudomonas species lipase by 1,2-ethylene-di-N-alkylcarbamates in detergents. 477 
Chemistry and Physics of Lipids, 146(2), 85–93. 478 
http://doi.org/10.1016/j.chemphyslip.2006.12.005 479 
Macierzanka, A., Sancho, A. I., Mills, E. N. C., Rigby, N. M., & Mackie, A. R. (2009). 480 
Emulsification alters simulated gastrointestinal proteolysis of β-casein and β-481 
lactoglobulin. Soft Matter, 5(3), 538–550. http://doi.org/10.1039/B811233A 482 
Maldonado-Valderrama, J., Wilde, P., Macierzanka, A., & Mackie, A. (2011). The role of bile 483 
salts in digestion. Advances in Colloid and Interface Science, 165(1), 36–46. 484 
http://doi.org/10.1016/j.cis.2010.12.002 485 
Mat, D. J. L., Le Feunteun, S., Michon, C., & Souchon, I. (2016). “in vitro” digestion of foods 486 
using pH-stat and the INFOGEST protocol: Impact of matrix structure on digestion 487 
kinetics of macronutrients, proteins and lipids. Food Research International, 88, 226–233. 488 
http://doi.org/10.1016/j.foodres.2015.12.002 489 
McClements, D. J., Decker, E. A., Park, Y., & Weiss, J. (2008). Designing food structure to 490 
control stability, digestion, release and absorption of lipophilic food components. Food 491 
Biophysics, 3(2), 219–228. http://doi.org/10.1007/s11483-008-9070-y 492 
Minekus, M., Alminger, M., Alvito, P., Ballance, S., Bohn, T., Bourlieu, C., … Brodkorb, A. 493 
(2014). A standardised static “in vitro” digestion method suitable for food – an 494 
international consensus. Food Funct. Food Funct, 5(5), 1113–1124. 495 
http://doi.org/10.1039/c3fo60702j 496 
Naikwade, S. R., Meshram, R. N., & Bajaj, A. N. (2009). Preparation and In Vivo Efficacy 497 
Study of Pancreatin Microparticles as an Enzyme Replacement Therapy for Pancreatitis. 498 




Prazeres, D. M. F., Garcia, F. A. P., & Cabral, M. S. (1994). Continuous lipolysis in a reversed 501 
micellar membrane bioreactor. Bioprocess Engineering, 10, 21–27. 502 
Reis, P., Holmberg, K., Watzke, H., Leser, M. E., & Miller, R. (2009). Lipases at interfaces: A 503 
review. Advances in Colloid and Interface Science, 147–148(C), 237–250. 504 
http://doi.org/10.1016/j.cis.2008.06.001 505 
Rovner, A. J., Schall, J. I., Mondick, J. T., Zhuang, H., & Mascarenhas, M. R. (2013). Delayed 506 
Small Bowel Transit in Children With Cystic Fibrosis and Pancreatic Insufficiency. 507 
Journal of Pediatric Gastroenterology and Nutrition, 57(1), 81–84. 508 
http://doi.org/10.1097/MPG.0b013e318290d112 509 
Sikkens, E. C. M., Cahen, D. L., Kuipers, E. J., & Bruno, M. J. (2010). Pancreatic enzyme 510 
replacement therapy in chronic pancreatitis. Best Practice & Research Clinical 511 
Gastroenterology, 24(3), 337–347. http://doi.org/10.1016/j.bpg.2010.03.006 512 
Turck, D., Braegger, C. P., Colombo, C., Declercq, D., Morton, A., Pancheva, R., … 513 
Wilschanski, M. (2016). ESPEN-ESPGHAN-ECFS guidelines on nutrition care for 514 
infants, children, and adults with cystic fibrosis. Clinical Nutrition, PublishAh(3), 557–515 
577. http://doi.org/10.1016/j.clnu.2016.03.004 516 
Waraho, T., McClements, D. J., & Decker, E. A. (2011). Impact of free fatty acid concentration 517 
and structure on lipid oxidation in oil-in-water emulsions. Food Chemistry, 129(3), 854–518 
9. http://doi.org/10.1016/j.foodchem.2011.05.034 519 
Whitcomb, D. C., Lehman, G. a, Vasileva, G., Malecka-Panas, E., Gubergrits, N., Shen, Y., … 520 
Caras, S. (2010). Pancrelipase Delayed-Release Capsules (CREON) for Exocrine 521 
Pancreatic Insufficiency due to Chronic Pancreatitis or Pancreatic Surgery: A Double-522 
Blind Randomized Trial. The American Journal of Gastroenterology, 105(10), 2276–523 
2286. http://doi.org/10.1038/ajg.2010.201 524 
26 
 
Zhu, X., Ye, A., Verrier, T., & Singh, H. (2013). Free fatty acid profiles of emulsified lipids 525 
during “in vitro” digestion with pancreatic lipase. Food Chemistry, 139(1–4), 398–404. 526 
http://doi.org/10.1016/j.foodchem.2012.12.060 527 
 528 
 529 
 530 
 531 
 532 
 533 
 534 
 535 
